Ethyl 5-Bromothiophene-3-carboxylate - CAS 170355-38-1

Name: Ethyl 5-Bromothiophene-3-carboxylate
Brand: BOC Sciences
Rating: 5 (1 reviews)

Catalog:	BB012635
Product Name:	Ethyl 5-Bromothiophene-3-carboxylate
CAS:	170355-38-1
Synonyms:	5-bromo-3-thiophenecarboxylic acid ethyl ester; ethyl 5-bromothiophene-3-carboxylate

Technical Data

Patents

Computed Properties

IUPAC Name:	ethyl 5-bromothiophene-3-carboxylate
Description:	Ethyl 5-Bromothiophene-3-carboxylate (CAS# 170355-38-1) is a useful research chemical.
Molecular Weight:	235.10
Molecular Formula:	C7H7BrO2S
Canonical SMILES:	CCOC(=O)C1=CSC(=C1)Br
InChI:	InChI=1S/C7H7BrO2S/c1-2-10-7(9)5-3-6(8)11-4-5/h3-4H,2H2,1H3
InChI Key:	LUYMKCLOYODOEI-UHFFFAOYSA-N
Boiling Point:	261.07 °C at 760 mmHg
Density:	1.573 g/cm³
LogP:	2.68730

Related Products

Online Inquiry

Name:

* Phone:

* Service & Products of Interested:

Project Description:

* Quantity:

* Email:

* Verification Code:

Customer Support

If the product you need is not in our catalog, please contact us in time to submit your needs. You can help our website get better and better. Why not submit the request today?

Submit Requirement

Customer Centered

Global Delivery

Warehouses in multiple cities to ensure fast delivery

Quality Assurance

Strict process parameter control to ensure product quality

Large Stock

> 20,000 building blocks and intermediates from stock

Process Scale-up

Process scale-up from lab to industrial scale

Flexible Batch Size

Flexible batch size for diverse industrial demands

Related Functional Groups

Carbonyl Compounds

[91125-43-8]C15H22O5S.Na
Sulfophenyl nonanoate sodium salt
[87-88-7]C6H2Cl2O4
Chloranilic acid
[55441-25-3]C8H7N3O
1-(2-Cyanophenyl)urea
[1035840-45-9]C14H16N2O4
1-(5-Methoxy-1,3-benzoxazol-2-yl)piperidine-3-carboxylic acid
[1006443-01-1]C9H6N4O4
1-(5-Nitropyridin-2-yl)-1H-pyrazole-3-carboxylic acid
[832741-29-4]C9H11BrOS
1-(4-Bromo-5-propylthiophen-2-yl)ethanone

Publication Number	Title	Priority Date
US-2021251982-A1	Methods for treating neurological symptoms associated with lysosomal storage diseases	20200203
WO-2021156769-A1	Methods for treating neurological symptoms associated with lysosomal storage diseases	20200203
WO-2020163244-A1	Methods for treating symptoms and disorders associated with lysosomal storage diseases	20190204
WO-2020163245-A1	Methods for treating symptoms and disorders associated with lysosomal storage diseases	20190204
WO-2020163337-A1	Treatment of ciliopathies using inhibitors of glucosylceramide synthase (gcs)	20190204

Complexity:	151
Compound Is Canonicalized:	Yes
Covalently-Bonded Unit Count:	1
Defined Atom Stereocenter Count:	0
Defined Bond Stereocenter Count:	0
Exact Mass:	233.93501
Formal Charge:	0
Heavy Atom Count:	11
Hydrogen Bond Acceptor Count:	3
Hydrogen Bond Donor Count:	0
Isotope Atom Count:	0
Monoisotopic Mass:	233.93501
Rotatable Bond Count:	3
Topological Polar Surface Area:	54.5
Undefined Atom Stereocenter Count:	0
Undefined Bond Stereocenter Count:	0
XLogP3:	2.8